ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 281.15
-4.53 (-1.59%)
At close: Aug 27, 2025
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
354.37K GBP
Profits / Employee
96.45K GBP
Market Cap
29.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Oxford Nanopore Technologies | 1,382 |
| HUTCHMED (China) | 1,811 |
ResMed News
- 2 days ago - Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds - GlobeNewsWire
- 2 days ago - ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows - Seeking Alpha
- 11 days ago - Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio - GlobeNewsWire
- 22 days ago - How Resmed’s Mick Farrell turned a $7b company into a $62b giant - The Australian Financial Review
- 23 days ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
- 25 days ago - ResMed RMD Q4 2025 Earnings Call Transcript - The Motley Fool
- 25 days ago - Nasdaq 100 and S&P500: Tech and Healthcare Stocks Lead US Indices Higher Today - FX Empire
- 4 weeks ago - ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings - Benzinga